2019nCoVR—A comprehensive genomic resource for SARS-CoV-2 variant surveillance

Código QR

2019nCoVR—A comprehensive genomic resource for SARS-CoV-2 variant surveillance

Guardado en:

Detalles Bibliográficos
Autores principales:	Guoqing Lu, Etsuko N. Moriyama
Formato:	article
Lenguaje:	EN
Publicado:	Elsevier 2021
Materias:	Science (General) Q1-390
Acceso en línea:	https://doaj.org/article/71a0ccfea09340498eef429569a2b03c
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Mechanism of action of favipiravir against SARS-CoV-2: Mutagenesis or chain termination?
por: Lei Zhao, et al.
Publicado: (2021)

Multiplex qPCR discriminates variants of concern to enhance global surveillance of SARS-CoV-2.
por: Chantal B F Vogels, et al.
Publicado: (2021)

Insights from Zimbabwe's SARS-CoV-2 genomic surveillance
por: Tafadzwa Dzinamarira, et al.
Publicado: (2021)

Data filtering methods for SARS-CoV-2 wastewater surveillance
por: Rezgar Arabzadeh, et al.
Publicado: (2021)

Comprehensive literature review on COVID-19 vaccines and role of SARS-CoV-2 variants in the pandemic
por: Charles Yap, et al.
Publicado: (2021)

Infecting human hematopoietic stem and progenitor cells with SARS-CoV-2
por: Hector Huerga Encabo, et al.
Publicado: (2021)

Isothermal amplification and fluorescent detection of SARS-CoV-2 and SARS-CoV-2 variant virus in nasopharyngeal swabs.
por: Les Jones, et al.
Publicado: (2021)

SARS-CoV-2 genomic surveillance in Rondônia, Brazilian Western Amazon
por: Luan Felipo Botelho-Souza, et al.
Publicado: (2021)

Point-of-Care Diagnostic Tools for Surveillance of SARS-CoV-2 Infections
por: Dhanasekaran Sakthivel, et al.
Publicado: (2021)

SARS-CoV-2 at the human-animal interphase: A review
por: Elmoubasher A. Farag, et al.
Publicado: (2021)

Detecting SARS-CoV-2 variants with SNP genotyping.
por: Helen Harper, et al.
Publicado: (2021)

Emergence of novel SARS-CoV-2 variants in the Netherlands
por: Aysun Urhan, et al.
Publicado: (2021)

The threat of the spread of SARS-CoV-2 variants in animals
por: D. Katterine Bonilla-Aldana, et al.
Publicado: (2021)

SARS-CoV-2 sewage surveillance in low-income countries: potential and challenges
por: Juliana Calabria de Araujo, et al.
Publicado: (2021)

Two doses of SARS-CoV-2 vaccination induce robust immune responses to emerging SARS-CoV-2 variants of concern
por: Donal T. Skelly, et al.
Publicado: (2021)

Antibody cocktail effective against variants of SARS-CoV-2
por: Kang-Hao Liang, et al.
Publicado: (2021)

SARS-CoV-2 spike protein: Site-specific breakpoints for the development of COVID-19 vaccines
por: Palaniyandi Velusamy, et al.
Publicado: (2021)

Prevalence of SARS-CoV-2 antibodies in France: results from nationwide serological surveillance
por: Stéphane Le Vu, et al.
Publicado: (2021)

SARS-CoV-2: fate in water environments and sewage surveillance as an early warning system
por: Deepak Panchal, et al.
Publicado: (2021)

Comparison of the Characteristics of Cytokine Storm and Immune Response Induced by SARS-CoV, MERS-CoV, and SARS-CoV-2 Infections
por: Liu T, et al.
Publicado: (2021)

Intranasal gene therapy to prevent infection by SARS-CoV-2 variants.
por: Joshua J Sims, et al.
Publicado: (2021)

Immune response to SARS-CoV-2 variants of concern in vaccinated individuals
por: Matthias Becker, et al.
Publicado: (2021)

The Disease Severity and Clinical Outcomes of the SARS-CoV-2 Variants of Concern
por: Lixin Lin, et al.
Publicado: (2021)

SARS-CoV-2 Variants, South Sudan, January–March 2021
por: Daniel Lule Bugembe, et al.
Publicado: (2021)

Alpha variant SARS-CoV-2 infection: How it all starts
por: Pere Domingo, et al.
Publicado: (2021)

UnCovid: A versatile, low-cost, and open-source protocol for SARS-CoV-2 RNA detection
por: Roberto Alcántara, et al.
Publicado: (2021)

Coronavirus (SARS-CoV-2): Preventions, keys to diagnosis and treatment of SARS-CoV-2
por: Kuldeep Singh Patel, et al.
Publicado: (2020)

COVseq is a cost-effective workflow for mass-scale SARS-CoV-2 genomic surveillance
por: Michele Simonetti, et al.
Publicado: (2021)

Molecular docking and dynamics studies on propolis sulabiroin-A as a potential inhibitor of SARS-CoV-2
por: Jaka Fajar Fatriansyah, et al.
Publicado: (2022)

Co-Occurrence of SARS-CoV-2 Infection and Inactivated SARS-CoV-2 Vaccination among Healthcare Workers
por: Cucunawangsih Cucunawangsih, et al.
Publicado: (2021)

Testing for SARS-CoV-2
por: Popadić Dušan
Publicado: (2021)

SARS-CoV-2 in cardiomyocytes
por: Josef Finsterer
Publicado: (2021)

Mouse-adapted SARS-CoV-2 protects animals from lethal SARS-CoV challenge.
por: Antonio Muruato, et al.
Publicado: (2021)

Mouse-adapted SARS-CoV-2 protects animals from lethal SARS-CoV challenge
por: Antonio Muruato, et al.
Publicado: (2021)

Immune response against SARS-CoV-2 variants: the role of neutralization assays
por: Alicja Maria Chmielewska, et al.
Publicado: (2021)

Molecular insights into receptor binding energetics and neutralization of SARS-CoV-2 variants
por: Melanie Koehler, et al.
Publicado: (2021)

SARS-CoV-2: Genetic variability, mutations and variants of concern for the global world
por: Ćupić Maja
Publicado: (2021)

Molecular and Serological Characterization of the SARS-CoV-2 Delta Variant in Bangladesh in 2021
por: Asish Kumar Ghosh, et al.
Publicado: (2021)

SARS-CoV-2 Variants, RBD Mutations, Binding Affinity, and Antibody Escape
por: Lin Yang, et al.
Publicado: (2021)

Common Laboratory Mice Are Susceptible to Infection with the SARS-CoV-2 Beta Variant
por: Ravi Kant, et al.
Publicado: (2021)